In one case, the neoplastic cells were CD5 positive, but negative for CD23, cyclin D1, and TCL1A; thus, a splenic localization of CLL/SLL or MCL was reasonably excluded. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.